Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurora Spine Corp (OP:ASAPF)

0.1437 -0.0056 (-3.75%)
Streaming Delayed Price Updated: 12:37 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aurora Spine Corp

< Previous 1 2 Next >
News headline image
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
Carlsbad, California and Tulsa, Oklahoma--(Newsfile Corp. - July 16, 2026) - Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV:... 
Via Newsfile
News headline image
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
- Company to Participate in the Lytham Partners Spring 2026 Investor Conference - 
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Issuance of Two U.S. Patents
Tenth Issued Patent for the ZIP™ Implant Family 
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Launches New Biologics Portfolio
New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics 
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
Award-Winning DEXA Technology™ Continues to Redefine Patient-Matched Spinal Care 
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces the Resignation of Board Director James Snow
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Company to Showcase Cutting-Edge Innovations at Booth #4510 
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
From Aurora Spine Corporation
Via GlobeNewswire
News headline image
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.